Summary of current small molecular drugs targeting PD-L1 and CD47. Small molecule chemical compounds block the function of major immune checkpoint molecules by (I) competitively binding with immune checkpoint molecules to block their combination with paired receptors (BMS202, CA-170, and IMMH-010 targeting PD-L1; NCGC00138783 and 1,2,4-oxadiazole…